Paul E. Brennan
University of Oxford · 449 works · 14,828 citations · h-index 58
Top works
- The promise and peril of chemical probes
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- Palladium-containing perovskites: recoverable and reuseable catalysts for Suzuki couplingsElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b3/b308465e/
- Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions
- PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
- Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
- Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
- Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
- K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac
- Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
- Synthesis of meta-substituted arene bioisosteres from [3.1.1]propellane
- Fragment-based hit identification: thinking in 3D
- British Society for Matrix Biology Spring 2021 Meeting: “Inflammation, Fibrosis, Resolution and the Matrix”
- A genetics-led approach defines the drug target landscape of 30 immune-related traits
- Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
- CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
- Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
- LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
- A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
- Recent Progress in Histone Demethylase Inhibitors